P13-02Comparison of HPV positivity of vaginal samples harvested by gynecologist and patient herself in Japan

13. Screening methods
K. Nakashima 1, K. Tadaichi 2, S. Jiro 1, Y. Hiroshi 1, S. Kazuyoshi 1, M. Atsushi 1.
1Department of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medicical Science (Japan), 2Japanese Foundation for Sexual Health Medicine (Japan)

Background / Objectives

It seems to be difficult for young Japanese girls to seek gynecological clinic and mount on the examining table because of embarrassment. In order to increase rate of cervical cancer examining test in young girls, it may reasonable to adopt HPV self-harvesting test(S sample). However, before adopting self-harvesting test, it is necessary to verify the superiority or non-inferiority of that compared to harvesting by a gynecologist (G sample). In this report, the superiority of self-harvesting test was examined.


Methods

Seventy four patients having more than slight dysplasia of the cervical region were examined in this study by using paired samples taken by a gynecologist and a patient herself in the same visiting date. Samples were examined by using a kit of GENOSEARCH HPV 31 which can identify 31 HPV genotypes including 13 high risk and 18 low risk HPV types.


Results

 In a result, HPV positive rate was higher but not significant in S samples of 78.4% (58/74 cases) compared to that in G samples of 70.3% (52/74 cases). Superinfection of HPV was likely to be detected more often in S samples than G samples . In each type of high risk HPV, positive case number of S samples was superior to that of G samples in most HPV types (7 vs 1).Quite same was observed in the case of low risk HPV (7 vs 1).


Conclusion

In summary, the HPV positivity of S samples was superior to that of G samples. It is considered that HPV sample-harvesting by patient herself is very useful not only for early diagnosis but also for early treatment of cervical cancer.


References

1) zur Hausen H, Meinhof W, Scheiber W, Bornkamm GW: Attempts to detect viral specific DNA sequences in human tumors: Ⅰ. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer 13: 650-656, 1974.                                                                                                                                                                                                                                                                  2) zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews Cancer 2: 342-350, 2002.
3) International Human Papillomavirus Reference Center. http://www.hpvcenter.se/html/refclones.html
4) Giuliano AR, Lee J-H, Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron J, Anic GM, Rollison DE, Smith D: Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 377: 932-940, 2011.
5) Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmern J, Uribe P, Velasco-Mondragn E, Nevarez PH, Acosta RD, Hernndez-Avila M: Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention: a community-based randomized controlled trial. Lancet 378: 1868-1873, 2011.
6) Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, Pan QJ, Ma JF, Niyazi M, Li CQ, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE: Pooled analysis of a self-sampling HPV DNA Teat as a cervical cancer primary screening method. J Natl Cancer Inst 104: 178-188, 2012.